DCT

1:15-cv-00451

Nalpropion Pharma Inc v. Actavis Laboratories FL Inc

General

Filed

06/03/15

Cause of ActionPatent Infringement

SectorBiotech

Status

Closed (10/20/20)

Patent Owner

Operating Company (W)

SourcePACER

Appeals18-1221

CourtD. Delaware

Judge	Period	PO Win Rate
Richard G. Andrews	06/10/15 - 11/16/20	33%

MagistrateMary Pat Thynge

Plaintiff

Party

Name	Ratings
Nalpropion Pharmaceuticals Inc	L2C
Takeda Pharmaceuticals USA Inc	L4A
Takeda Pharmaceuticals LLC	L4A
Takeda Pharmaceuticals Intl AG	L4A
Takeda Pharmaceuticals America Inc	L4A
Takeda Pharmaceutical Co Ltd	L4A
Orexigen Therapeutics Inc	L2C

Attorney

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5A
Stephen J. Kraftschik	L5A
Rodger D. Smith, II	L5A
Mary B. Graham	L5B
Fitzpatrick Cella Harper & Scinto	L4A
Dominick A. Conde	L5A
Christopher P. Borello	L5B
Paul Hastings LLP	L4D
Bruce M. Wexler	L5A
Simon F. Kung	L2A
Michael F. Werno	---- --
Patterson Belknap Webb & Tyler LLP	L3B
William F. Cavanaugh, Jr.	L5A
Irena Royzman	L5B
Chad J. Peterman	L5B
Zhiqiang Liu	L4B
Andrew D. Cohen	L3C

Defendant

Party

Name	Ratings
Actavis Laboratories FL Inc	L5E
Andrx Corp	L5E
Actavis LLC	L5E
Actavis Inc	L5E
Actavis Pharma Inc	L3E

Attorney

Name	Ratings
Greenberg Traurig LLP	L5D
Justin A. MacLean	L5E
Richard C. Pettus	L5E
Scott J. Bornstein	L5E
Jonathan D. Ball	L4E
Richard Mills-Robertson	L4E
Rachel Wu	---- --
Young Conaway Stargatt & Taylor LLPLocal	L4D
James L. Higgins	L5C
Melanie K. Sharp	L5D
Monte T. Squire	L5D
Robert M. Vrana	L5D
Willkie Farr & Gallagher LLP	L3E
Eugene L. Chang	L5B
Michael W. Johnson	L5D
Thomas J. Meloro	L5E
Dan Constantinescu	L3E